The Research Institute for Medicines (iMed.ULisboa) is a R&D Unit at Faculty of Pharmacy, University of Lisbon that promotes pharmaceutical research to improve human health through disease prevention, diagnosis and treatment.
Our translational activities span the spectrum of Drug discovery, design, development and usage in human diseases, such as cancer and neurodegenerative, metabolic and infectious disorders.
Company Details
- Employees
- 78
- Address
- Fac. Farmácia Da Ulisboa - Avenida Professor Gama Pinto, Lisboa,1649-003,portugal
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://imed.ulisboa.pt
- Keywords
- Research Institute for Medicines.
- HQ
- Lisboa
- Competitors
- UMCG research, Instituto de Medicina Molecular, Calouste Gulbenkian Foundation, AEFFUL, iMed.ULisboa Postgraduate Students Commission (ipSC), FLxFlow - Lisbon Flow Cytometry Network, iBET - Instituto de Biologia Experimental e Tecnológica, CUF - Hospitais e Clínicas, GIMM, iBB-Institute for Bioengineering and Biosciences.
Imed.ulisboa Questions
Imed.Ulisboa's website is http://imed.ulisboa.pt
Imed.Ulisboa's LinkedIn profile is https://pt.linkedin.com/company/imed.ulisboa
Imed.Ulisboa has
78 employees.
View email and phone details for 78
employees at Imed.Ulisboa.
Imed.Ulisboa's industry is
Research Services
Imed.Ulisboa's top competitors are
Umcg Research,
Instituto De Medicina Molecular,
Calouste Gulbenkian Foundation,
Aefful,
Imed.ulisboa Postgraduate Students Commission (Ipsc),
Flxflow - Lisbon Flow Cytometry Network,
Ibet - Instituto De Biologia Experimental E Tecnológica,
Cuf - Hospitais E Clínicas,
Gimm,
Ibb-Institute For Bioengineering And Biosciences.
Imed.Ulisboa's categories are Research Services
